“RDIF and one of the leading pharmaceutical manufacturers in Uzbekistan - Jurabek Laboratories - announce the production of the first batches of the Russian Sputnik V coronavirus vaccine.

The drug produced in Uzbekistan will be used to implement a program of vaccination of the population against coronavirus in the country, ”the fund said.

Sputnik V was certified for use in Uzbekistan in February 2021.

Earlier it was reported that Turkey intends to start production of the Sputnik V vaccine in the near future.